Getting Oriented: Who's In The Room?

• Which role best describes you in this conversation? Options: VP Quality, Director of Regulatory Affairs, Quality Systems Manager, Head of IT/Infrastructure, Site/Plant Quality Lead, Other
• What site(s), business unit(s), or product lines will this QMS rollout affect?
• Who will be the primary day-to-day contact for configuring workflows and approvals? Options: Quality Manager, Process Owner, IT Business Analyst, Compliance Lead, Other
• Who in your organization signs commercial contracts and validation commitments? Options: VP/Head of Procurement, VP Quality, Legal, Finance, Other
• Roughly how many people will use the QMS (for analytics): operators, engineers, QA, and leaders combined? Options: <25, 25–100, 101–500, 501–2000, >2000

Who Really Decides — and Why It Matters

• If a vendor shipped an out‑of‑the‑box QMS that fixed your 483 findings but required faster process changes than teams are ready for, who would ultimately decide whether to proceed? Options: VP Quality, Director Regulatory, Head of Manufacturing, CISO/IT, CEO/COO, Cross-functional committee
• List the 3–5 individuals or roles who must be explicitly aligned before a purchase can be signed (names or titles).
• Which stakeholders have veto power over the validation approach (e.g., pre‑validated config vs custom)? Options: Quality, Regulatory, IT/Security, Operations, Legal, Other
• What are the top motivations each decision-maker has (pick the dominant drivers)? Options: Close audit gaps quickly, Minimize IT validation burden, Preserve existing workflows, Lower total cost of ownership, Speed to market/shipments, Improve traceability for inspections
• Have any of these decision-makers stalled previous quality technology projects—if so, what was the main cause? Options: Validation timeline concerns, Budget constraints, Integration complexity, Change resistance, No prior experience with vendor, Not applicable

If an Inspector Walked In Tomorrow, What's the Single Biggest Risk?

• Which specific Form 483 observations, ISO findings, or internal audit results are driving this project now? Options: CAPA timeliness, Incomplete training records, Document control gaps, Traceability issues, Nonconformance handling, Supplier quality
• How recent/severe were those findings (help us understand urgency)? Options: Active Form 483 within 6 months, 483 within last 1–2 years, ISO major/nonconformity in last audit, Recurring internal audit findings, Historical but unresolved issues
• Which paper-based controls or spreadsheets today create the highest risk of audit escalation?
• What is the tangible business consequence if shipments were paused due to an inspection outcome? Options: Temporary localized delay, Major site shutdown, Loss of a key customer contract, Regulatory Recall/Corrective Action, Unknown/not quantified
• How does that risk make you or your team feel—frustrated, anxious, resigned, motivated? Tell us briefly.

What Would Auditors Need to See to Close the Chapter?

• Which concrete acceptance criteria would make an auditor—and your leadership—consider this risk resolved?
• Which regulatory frameworks and standards must the solution demonstrably satisfy? Options: 21 CFR Part 820 (Medical Device), 21 CFR Part 11 (Electronic Records), ISO 13485, EU MDR, cGMP/Pharmaceuticals, AS9100 (Aerospace), Other
• Which types of evidence are non-negotiable for sign-off (select all that apply)? Options: Training completion records, Audit trail of document changes, MP traceability from process to device, CAPA lifecycle evidence, IQ/OQ/PQ deliverables, Supplier audit history
• What measurable signals (e.g., % training completion, average CAPA closure time, audit‑ready documents) would you track to prove success?
• Would your auditors accept a vendor-provided pre‑validated configuration with supplied IQ/OQ documentation, or do you require in‑house development of validation artifacts? Options: Vendor pre-validated configuration acceptable, Vendor docs acceptable with customer review, Require in-house tailored IQ/OQ, Unsure—need to confirm with auditors

IT: The Invisible Project Manager — Can They Make the Timeline?

• How would you describe your IT organization's tolerance for a validated SaaS QMS that requires limited on‑premise work? Options: Eager and experienced, Cautious but supportive, Resource-constrained, Skeptical of SaaS due to security
• Which systems must this QMS integrate with for go‑live (select all that apply)? Options: ERP (SAP/Oracle/etc.), PLM, MES, LIMS, Identity provider (SSO), None / Standalone
• Do you have an internal or external validation policy that prescribes specific IQ/OQ formats or retention requirements? Options: Internal policy with templates, External/ Third-party policy, No formal policy, Unsure
• How many IT FTEs can be allocated during the validation period (estimate)? Options: None, 0.5–1, 1–3, 4–6, 7+
• What is your preferred validation approach to reduce IT effort: pre‑validated config, phased validation, or full custom validation? Why? Options: Pre-validated configuration, Phased validation (critical modules first), Full custom validation, Hybrid

Drawing the Line: What’s In Scope and What’s Not?

• If you had to name three must-have modules for first release, which would they be? Options: Document Control, Training Management, CAPA, Nonconformance / Scrap, Audit Management, Supplier Quality
• Which modules would you consider for a later phase (not required at go‑live)? Options: Supplier Portal, Advanced Analytics, PLM integrations, Device History Record, Quality Events
• What are your expectations for vendor vs customer responsibilities during migration (e.g., vendor provides mapping and scripts, customer reviews records)?
• Do you expect pre-populated, pre‑validated components (templates, workflows, IQ/OQ) or a fully bespoke build? Options: Prefer pre-validated components, Prefer bespoke configuration, Combination of both, Undecided
• What data migration boundaries would feel acceptable (e.g., migrate last 3 years of records, archive older docs)? Options: Last 12 months, Last 3 years, All active documents, Selective by risk category, Other

Adoption Reality Check: Will People Actually Use It?

• What have you seen derail past quality system rollouts—people, process, or technology? Options: Insufficient training, Lack of executive mandate, Poor change management, Complex user experience, Integration failures
• How does your team prefer to learn new systems (select all that apply)? Options: Hands-on workshops, Recorded on-demand training, Train-the-trainer, Role-based guided walkthroughs, Written manuals
• How long of a parallel-run (paper + system) would you require before accepting the QMS as authoritative? Options: 1–2 weeks, 3–6 weeks, 2–3 months, 4+ months, No parallel run preferred
• Which measurable adoption KPIs would convince leaders this is working (pick top 3)? Options: % Training Completion, Mean Time to Close CAPA, Number of Audit Findings, Document turnaround time, User login/engagement
• What internal change champions or teams would you empower to sustain adoption post‑go‑live?

So — What Would It Take To Say Yes?

• If we could guarantee closing your top audit gap within X weeks, what would X need to be for you to feel comfortable proceeding? Options: 2–4 weeks, 5–8 weeks, 9–12 weeks, 13–24 weeks, Unsure
• What are non-negotiable contract items or proof points you need before signing (e.g., references from similar regulated manufacturers, SLA, IQ/OQ delivery dates)? Options: Industry references, Fixed IQ/OQ delivery timeline, SLA for uptime/support, Security attestation (SOC2), Custom contract terms
• What budget cycle or procurement timeline constraints should we know about? Options: Committed budget this quarter, Next quarter budget, Annual planning window, Unclear/Ad hoc approval
• What would a realistic next step look like from your perspective (e.g., compliance gap assessment, pilot configuration, executive review)? Options: Gap assessment, Pilot configuration with sample workflows, Executive briefing/demo, Proof of concept with data migration test, Other
• Who else should we involve on our next call to remove a blocker or accelerate decision-making (name or role)?

Your Recent Wake‑Up Call

• When was the regulatory observation or audit finding that prompted this initiative? Options: Within 30 days, 30–90 days, 3–12 months, Over a year, Proactive / no finding
• Which role first raised the need to replace paper/spreadsheets after that event? Options: VP Quality, Quality Systems Manager, Director of Regulatory Affairs, Plant Manager / Operations, IT, Other
• Which specific Form 483 observations or ISO clauses were cited? Please list numbers and short phrases (e.g., ‘483: CAPA timeliness’).
• How did leadership react—did the finding change budget, timelines, or executive attention? Options: Immediate budget & timeline change, Budget approved; timeline TBD, Executive escalation only, No substantial change, Unsure
• Tell us briefly about the single sentence from the auditor that still bothers you.

If We Keep Doing Things the Same, What Breaks Next?

• How likely is it that an unresolved observation will escalate to a warning letter or shipment hold? Options: Very likely, Somewhat likely, Uncertain, Unlikely, No risk
• If shipments were paused for one site for one month, what would be the top business impacts? Options: Revenue loss, Customer penalties/SLAs, Production backlog, Supply chain disruption, Brand/reputation damage, Other
• Which stakeholders become most vocal when regulatory risk rises (who drives decisions under pressure)? Options: Legal, Quality, Regulatory Affairs, Manufacturing Ops, Supply Chain, Commercial, Executive Leadership
• How do you currently quantify the risk of non‑compliance (financial, operational, reputational)? Options: Detailed modeled estimate, High‑level estimate, Qualitative only, Not measured, Other
• What would have to happen for you to consider this problem urgent enough to pause other projects?

Where the Paper Lives (and Why It Still Works…Sometimes)

• Why are critical controls still managed on paper or spreadsheets rather than a digital QMS? Options: Legacy culture / comfort, Budget constraints, No fit-for-purpose software found, Complex/unique workflows, IT validation burden, Other
• List the document types and controls that remain paper/spreadsheet-driven (e.g., batch records, CAPA initiation, training sign-offs).
• How are approvals, versioning and archival handled for those paper records today? Options: Wet signatures + binders, Scanned copies with manual index, Share drives/SharePoint w/ manual updates, Excel trackers, No formal process
• How often do those manual processes cause a missed release, lost evidence, or audit observation? Options: Daily, Weekly, Monthly, Rarely, Unknown
• Describe one concrete example where a paper/spreadsheet control directly created audit or shipment risk.

What the Findings Actually Say (Not What You Told Us)

• If you had to summarize the auditor’s main accusation about your control system in one blunt sentence, what would it be?
• Which of these findings apply to your situation? (Select all that match.) Options: Form 483 – CAPA timeliness, Form 483 – Incomplete training records, Form 483 – Document control gaps, ISO clause – Documented procedures missing, ISO clause – Training competence, ISO clause – Traceability/record integrity, Other
• For each active finding, who is the documented owner and who is actually doing the remediation work?
• What evidence do you already have that would demonstrate remediation effectiveness (root cause analyses, corrective action plans, training logs, verification records)? Options: Root cause documents, Corrective action plans, Training logs, Verification/closure evidence, Minimal / scattered, None
• How confident are you that your current evidence package would satisfy an FDA/ISO auditor today? Options: Very confident, Somewhat confident, Not confident, Unsure

How Work Actually Flows — Walk Me Through It

• Walk us through the last CAPA or nonconformance that slipped: what were the exact handoffs and where did progress stall?
• Across the lifecycle (detection → investigation → CAPA plan → implementation → verification → closure), which stage typically takes the longest? Options: Detection, Investigation, CAPA plan approval, Implementation, Verification, Closure, All stages are slow
• How are tasks and deadlines assigned and tracked right now? Options: Email, Spreadsheets, Paper forms, Existing QMS software, Ticketing system, Other
• On average, how many people/teams are involved before a deviation is closed (including reviewers and approvers)? Options: 1–2, 3–5, 6–10, 10+, Varies widely
• What manual checkpoints or signoffs must occur before a lot release or shipment that could be automated or digitized?

Where Data Hides and Why It Matters

• If an auditor asked for training evidence tied to a specific lot produced six months ago, how quickly could you produce it? Options: Under 1 hour, Same day, Several days, Weeks, Cannot produce
• Where are your training records and matrices currently stored? Options: Paper binders, Excel/Access trackers, LMS, SharePoint, Existing QMS, Other
• What percent of employees typically have overdue or incomplete training at any point? Options: <5%, 5–15%, 16–30%, >30%, Unknown
• What are the main reasons training or competence records are missing (e.g., new hires, system errors, legacy records not migrated)?
• Do you currently have immutable audit trails and timestamps for critical actions (document approval, training completion, CAPA status)? Options: Yes – full audit trail, Partially, No, Unsure

Who Gets Blamed Versus Who Can Fix It

• When an audit finding appears, who publicly owns the problem—and who actually executes the fix?
• Which departments must be actively involved for remediation to succeed? Options: Quality, Regulatory Affairs, Manufacturing, R&D/Engineering, IT, Supply Chain, Legal, HR, Other
• How empowered is your IT organization to support a validated system rollout within an accelerated timeline? Options: Highly empowered (dedicated resources), Somewhat empowered (shared resources), Constrained (other priorities), Not empowered, Unsure
• What internal approval gates or policies routinely delay computer system validation or configuration changes?
• Have past projects been delayed by requiring custom code versus configuration? How do you feel about ‘no‑code’ workflow configurability? Options: Custom code common and accepted, Prefer configuration/no-code, Mixed experience, No preference

Integration Reality Check — Bridges or Blockades?

• If we provided a pre‑validated QMS designed to integrate with your systems, what single integration risk concerns you most?
• Which systems must the QMS integrate with (select all that apply)? Options: ERP (e.g., SAP), PLM (e.g., Windchill), MES, LIMS, LMS, Electronic Signatures / eForms, Other
• Do you have API documentation, data dictionaries, or mapping inventories available today? Options: Complete and accessible, Partial, None, Don't know
• How many unique product SKUs/configurations and suppliers would need to be represented or mapped during migration? Options: <100, 100–500, 500–2,000, 2,000+, Unknown
• Who on your team will own integration testing and ongoing interface maintenance?

What Passing Looks Like — Beyond ‘Fixed’

• If an external auditor arrived tomorrow, what minimal evidence set would make them stop asking questions?
• Which measurable acceptance criteria will you use to declare the QMS deployment a success? Options: No repeat findings on key clauses, 100% training completion, CAPA closed within target days, Traceability for last X lots, Audit readiness score improvement, Other
• What reporting or dashboard signals does leadership expect to see to feel the risk is reduced?
• Are there specific validation artifacts you require out‑of‑the‑box (IQ/OQ templates, traceability matrices, CSV scripts)? Options: IQ templates, OQ templates, Traceability matrix, CSV/data migration scripts, Validation plan, Other
• Which go/no‑go criteria would block a production cutover? Options: Unresolved critical findings, Failed integration tests, Training incomplete, Validation not approved, Other

Data & Migration Reality — How Messy Is It?

• How many documents, records, and database rows would need migration (rough order of magnitude)? Options: <10k, 10k–50k, 50k–200k, 200k–1M, 1M+
• Are legacy records consistently indexed and searchable today? Options: Yes, Partially, No, Don't know
• What kinds of data quality issues do you expect during migration (duplicates, missing metadata, scanned poor-quality documents)? Options: Duplicates, Missing metadata, Unreadable scans, Incorrect version history, Other
• Do you require preservation of original timestamps, authorship, and approval evidence in migrated records? Options: Yes – must preserve, Prefer to preserve, Not required, Unsure
• Who will be the final approver of migrated data and acceptance criteria for a successful migration?

Quick Wins and the First Risks to Mitigate

• What two actions could we take in the first 30 days that would materially reduce audit or shipment risk?
• Which of the following are feasible immediate mitigations your team can commit to in 30 days? Options: Locking document control (freeze edits), Complete overdue high‑risk trainings, Triage and prioritize CAPAs, Isolate affected product lots, Begin targeted data backups, Other
• Who must sign off to enact those quick mitigations immediately? Options: VP Quality, Director Regulatory, Plant Manager / Site Lead, IT Director, COO, Other
• Would you prefer an accelerated validated configuration delivered quickly (shorter validation) or a slower bespoke configuration tuned perfectly to today’s processes? Options: Accelerated pre‑validated configuration, Slower bespoke configuration, Hybrid (pre‑validated core + small customizations), Undecided
• Is there any critical information we haven’t asked that would change how we prioritize remediation?

Quick Check: Who's in the Room?

• Which roles will be directly involved in the Pre-Deployment activities for this QMS rollout? Options: VP Quality, Quality Systems Manager, Director of Regulatory Affairs, IT Director/Manager, Validation Engineer, Document Control Lead, Project Manager, Other (please name)
• What is your target date for beginning validation activities (IQ/OQ) in a production-like environment? Options: Within 2 weeks, 2–4 weeks, 1–3 months, 3–6 months, No timeline yet
• How urgent is avoiding a regulatory escalation (e.g., warning letter or shipment hold) as a driver for accelerating deployment? Options: Mission critical — must avoid escalation immediately, High priority — serious concern, Moderate — one of several priorities, Low — planning for future
• Who should receive all major deployment updates and decisions (names or roles)?

What If the Inspection Happened Tomorrow?

• If an FDA/ISO inspection landed next week, which operational gaps in your current environment would most likely be cited? Options: Training records incomplete, Document control gaps, CAPA lifecycle evidence missing, Traceability/lot tracking gaps, Validation evidence not available, Other (please describe)
• How confident are you that the target deployment environments (test/UAT/stage/prod) already meet your company's security and compliance standards? Options: Fully confident, Mostly confident with minor gaps, Unsure — we need to verify, Not confident — major work needed
• Describe a recent audit observation (Form 483/ISO finding) that still influences your deployment decisions today.
• What would be the immediate operational consequence if the deployment were delayed beyond your target date? Options: Shipment delays, Increased audit risk, Temporary manual workarounds, Resource reallocation, No immediate consequence, Other (please explain)

Where Are The Hidden Hand-offs?

• Who formally owns each of these areas today: environments provisioning, data migration, validation protocols, integrations (ERP/PLM), and user access control? Options: Quality, IT, Validation/CSV, Operations/Manufacturing, External Vendor/Consultant, Not assigned / unclear
• How aligned are those owners on responsibilities, SLA-style handoffs, and escalation rules? Options: Completely aligned, Mostly aligned with known gaps, Misaligned and needs coordination, No alignment — roles unclear
• When a deployment task slips, what is your current escalation path and who makes the final go/no‑go call?
• List any external partners (cloud provider, systems integrator, validation consultant) and their primary responsibility for Pre-Deployment readiness.

Is Your Data Ready for the Spotlight?

• Which data sets are in scope for migration before validation starts (documents, training records, CAPAs, supplier files, BOM/part masters)? Options: Documents & SOPs, Training records, CAPA histories, Nonconformance records, Supplier quality files, ERP/PLM master data, Other (please list)
• Rate the current state of that data: completeness, accuracy, and audit trail preservation. Options: Mostly complete and clean, Moderate cleanup required, Significant remediation required, Data not assessed yet
• What criteria will you use to accept migrated records in the target system (fields, version history, signatures, timestamps)?
• Have you performed a sample migration and reconciliation? If yes, what percent matched and what were the top error types? Options: Yes — >95% match, Yes — 80–95% match, Yes — <80% match, No sample migration yet
• Are there any records that legally or regulatorily must remain in the legacy system or retain their original audit trail? Options: Yes, No, Unsure — need to confirm

Can IT Deliver Without Losing Sleep?

• If IT had to provide daily support for validation and environment provisioning for the next 6 weeks, what impact would that have on other projects? Options: Critical impact — we’d need to re-prioritize, Moderate impact — manageable, Minor impact, No impact
• Which environment types do you need provisioned and who will host them (on‑prem, private cloud, vendor‑hosted SaaS)? Options: On‑prem, Private cloud, Vendor‑hosted SaaS, Hybrid
• What are your non‑functional requirements for these environments (backup frequency, retention, disaster recovery RTO/RPO, encryption)?
• Would pre-validated environment templates and vendor-supplied IQ/OQ reduce your IT validation hours enough to meet your timeline? Options: Yes — significantly, Possibly — somewhat, No — not enough, Unsure — need to see the artifacts
• How many dedicated IT/validation FTEs can you reasonably commit during the critical pre-deployment window? Options: <1, 1–2, 3–5, 6–10, >10

How Will You Know You’ve Passed?

• What are your must-have acceptance criteria for IQ/OQ/PQ (examples: test pass rate, documented traceability, signed training records)?
• Which stakeholders must sign off on validation artifacts before go‑live (roles, not names)? Options: Quality, Validation/CSV, IT Security, Regulatory Affairs, Operations/Manufacturing, Executive Sponsor
• Do you require independent third‑party validation review or will internal validation suffice? Options: Internal validation only, Third‑party review required, Prefer third‑party but not required, Unsure
• How will you measure 'audit readiness' once validation is complete (specific signals or metrics)? Options: Complete IQ/OQ docs, Training completion %, records verified, Traceability matrix signed off, Zero critical open CAPAs related to system, Other (please define)
• What is an acceptable window between validation completion and the next inspection for you to feel confident? Options: <1 month, 1–3 months, 3–6 months, No constraint

What Could Break During Parallel Runs?

• When you run the new QMS in parallel with legacy processes, what single failure mode worries you most? Options: Data mismatch between systems, Operators skipping steps, Training not reflected in practice, Integration failures with ERP/PLM, Audit trail inconsistencies, Other (please describe)
• How will you validate that parallel-run outcomes are equivalent or better than legacy results (sample size, KPIs, timeframe)?
• Who will manage exceptions discovered during parallel runs and how will they be tracked and closed? Options: Quality, Operations, IT, Project Manager, Cross-functional team
• What training or on‑the‑job supports are planned to prevent human error during parallel operation? Options: Instructor-led training, Job aids/work instructions, Shadowing/mentoring, Short checklists in system, No plan yet
• Have you defined criteria for stopping the parallel run and reverting to legacy systems if critical issues arise? Options: Yes — clear stop criteria, Partially defined, No

Commitments, Timelines, and Escalation Paths

• Which fixed milestones must be met before deployment (e.g., environment signoff, sample migration validation, IQ complete, OQ complete, training complete)? Options: Environment provisioned, Sample migration verified, IQ complete, OQ complete, Training records verified, Go/No‑Go review
• Who holds the budget and who holds the final approval authority for go-live?
• If a critical blocker emerges within two weeks of planned go-live, what is your preferred remediation path: delay, scope reduction, or emergency resourcing? Options: Delay go-live, Reduce scope for phased rollout, Bring in emergency resources, Other (please specify)
• What communication cadence and format would make stakeholders feel informed but not overwhelmed (weekly summary, dashboards, daily standups)? Options: Weekly executive summary, Weekly tactical meeting, Daily standup during critical window, Shared dashboard with alerts, Ad hoc as issues arise
• Who is your rapid‑response contact for 24/7 critical deployment incidents (role and backup)?

Last Mile: What Would Make You Confident?

• What vendor-provided artifacts would most reduce your validation burden and give leadership confidence (e.g., pre-built IQ/OQ, mapping templates, test scripts, traceability matrices)? Options: Pre-built IQ/OQ, Migration mapping templates, Executable test scripts, Traceability matrix templates, Reference customer validations, Other (please list)
• Which reference customers (industry/size) would you like to speak with before committing to the validation timeline? Options: Medical device — similar size, Pharma — similar size, Aerospace — similar size, Food/CPG — similar size, No references needed
• How much validation artifact pre-work from the vendor would shift your internal timeline from months to weeks? Options: Full IQ/OQ + scripts, IQ/OQ templates only, Migration templates + sample executions, Documentation review only, None — we need to do internally
• What would you consider a successful outcome at the end of Pre-Deployment Readiness (one short sentence)?
• Are you ready to schedule a focused readiness workshop (2–4 hours) to convert these answers into a concrete go/no‑go plan? Options: Yes — schedule now, Yes — after internal review, Maybe — need more info, No — not ready

Start: What's the Story Behind Your 483?

• Briefly describe the inspection finding or audit trigger that brought you to consider a new QMS today.
• Which of these findings best matches your trigger? Options: Form 483 observation - CAPA timeliness, Form 483 observation - Incomplete training records, ISO audit finding - Document control gaps, Supplier quality / incoming inspection issues, Other
• When did the inspection or audit occur (date or relative timeframe)? Options: Within 30 days, 30-90 days ago, 3-6 months ago, More than 6 months ago
• Which sites, product lines, or suppliers were implicated? Please list the ones that matter most for risk and remediation.
• What immediate steps have been taken to close the observation(s), and who owns them?
• Current status of the regulatory risk from this finding? Options: Open and actively remediating, Open but progress stalled, Closed with follow-up commitments, Escalated to executive leadership

If This Escalates, What's the Cost?

• Imagine the next inspection escalates to a Warning Letter—what would that actually do to your ability to ship product, retain customers, or meet contracts?
• Which of these consequences would be most immediate? Options: Shipment holds, Customer contract penalties, Manufacturing suspension, Product recalls, Regulatory fines, Reputational damage
• Do you have a quantified estimate of revenue at risk or the cost to remediate an escalation? Options: Yes - precise estimate, Yes - rough estimate, No estimate available
• How would an escalation change leadership's appetite for rapid digital remediation versus manual fixes? Options: Demand urgent investment in a validated system, Support but require heavy justification, Prefer short-term manual mitigation only, Undecided
• How is the stress from this risk affecting your team's capacity and morale right now?

Who's Actually Making the Call?

• Who must be convinced internally and externally before a new validated QMS can be purchased and signed off? Options: VP/Head of Quality, Director of Regulatory Affairs, IT / Infrastructure Lead, CFO / Procurement, Manufacturing/Operations Leader, Quality System Manager, External consultants or auditors
• What is the typical approval timeline and gating process for software purchases of this scale in your organization? Options: 0-30 days, 30-60 days, 60-90 days, 90-180 days, More than 180 days
• What are the non-negotiable acceptance criteria each stakeholder group will insist on (be specific about documentation, signatures, or metrics)?
• Who will own computer system validation (CSV) internally, and how much external support will they accept? Options: Quality owns CSV, IT owns CSV, Shared Quality + IT, Third-party validation consultant, Not yet decided
• Which proof points or references matter most to your decision-makers (pick top three)? Options: Similar-size medical device reference, Pharma regulatory case study, Pre-validated IQ/OQ delivery history, ERP/PLM integration examples, Time-to-validate reductions documented, Audit-ready reference customers
• What keeps your decision-makers awake at night when evaluating a QMS vendor?

Where Is the Paper Trail Breaking Down?

• If you had to bet, which manual workflow is most likely to be cited again on the next audit? Options: CAPA lifecycle and effectiveness checks, Training assignment, completion, and proof, Document revision control and approvals, Supplier nonconformance and incoming QC, Batch release traceability
• How are training completions and competency tracked today? Options: Spreadsheets, Shared drives with manual logs, Generic LMS without traceability, ERP/HR system, Paper records only
• How often do you discover gaps in CAPA timeliness or effectiveness, and how are those gaps currently documented? Options: Weekly, Monthly, Quarterly, Occasionally, Rarely
• Give a recent, concrete example where a paper-based control failed an audit—what happened, who was affected, and what was the remediation?
• What manual workarounds do people use to create traceability between deviation, CAPA, and release decisions?
• Which current tools and storage locations hold your quality records today? Options: Spreadsheets, Network file shares, Paper archives, Generic Document Management System, ERP modules, Homegrown application, LIMS/MES
• How confident are you that your legacy records, as-is, would satisfy an auditor’s request for traceability? Options: Very confident, Somewhat confident, Doubtful, Not confident at all

What Would Audit-Ready Look Like Tomorrow?

• If an inspector left satisfied tomorrow, what exactly would they have seen in terms of records, workflows, and evidence?
• Which of these acceptance signals would most reassure auditors and leadership? Options: Complete training matrix with timestamps and signatures, CAPA records with root cause and effectiveness checks, Document control with full change history and approvals, Traceability from DHR to nonconformance and CAPA, Delivered IQ/OQ evidence for the system
• What minimum validation deliverables must you see before your team will accept the system? Options: Installation Qualification (IQ), Operational Qualification (OQ), Performance Qualification (PQ), Validation plan and traceability matrix, User acceptance / acceptance test scripts, Updated SOPs and user training records
• Who will be authorized to sign acceptance tests and formal validation records? Options: Quality Owner, Regulatory Owner, IT Owner, Cross-functional sign-off committee, External QA reviewer
• What measurable KPIs would prove to leadership that the new QMS has lowered audit risk?
• How quickly would those KPIs need to shift to reassure executives? Options: Within 30 days, 30-90 days, 90-180 days, Longer than 180 days

What Would a Faster Validation Mean?

• If validation could be shortened from six months to six weeks, would that change your go/no-go decision—and how? Options: Yes, we'd accelerate purchase, Yes, but only with additional assurances, No, timeline isn't the blocker, Unsure
• Which validation supports would matter most to you to enable a rapid timeline? Options: Pre-built IQ/OQ documentation, Pre-validated configuration templates, Validation test scripts for workflows, Migration validation tools and scripts, Onsite validation assistance
• List the integrations that must exist at go-live (pick all that apply). Options: ERP (SAP, Oracle), PLM, MES, LIMS, HR / LMS, SSO / Active Directory, None required at go-live
• Describe your IT and validation resource availability for a condensed, 4-6 week validation window.
• What migration boundaries are absolute (what data/records must be migrated vs. what can stay archived)?
• Would you accept a phased deployment (core compliance modules first) to accelerate validation? Options: Yes - core modules first, Yes - pilot site first, Prefer full feature deployment, Undecided

Pain Points, Deal-Breakers, and Small Wins

• What's the single capability or vendor behavior that would make you walk away from any QMS evaluation today?
• Which of the following are absolute deal-breakers for your team? Options: No pre-validated components/IQ-OQ, Requires heavy custom code to model workflows, Cannot integrate with ERP/PLM, Insufficient audit trail and versioning, Poor training and enablement offerings, Lack of references in our vertical
• What small, early wins would make stakeholders more comfortable taking a larger step (examples: pilot on a single process, documented IQ/OQ for one module)?
• Which training approach is most likely to drive adoption for your users? Options: Role-based hands-on sessions, Train-the-trainer model, Short recorded modules + quizzes, On-the-floor shadowing during parallel runs, Workshop-led scenario training
• What post-go-live support and governance model would make your team feel safe? Options: Dedicated customer success manager, Validation support package, Embedded onsite support for initial period, Regular executive business reviews, Community and peer references
• Are there internal political or adoption risks we should plan for? If so, describe the groups, their likely objections, and past change efforts.

Next Steps — What's the Fastest Way Forward?

• If we built a 30-day proof-of-value for your team, what would it absolutely need to demonstrate to earn a pilot-to-purchase recommendation?
• Who are the essential people we must include in a 30-day pilot to make decisions afterward? Options: VP Quality, Quality System Manager, Director Regulatory Affairs, IT Lead / Architecture, Validation Lead, Manufacturing Representative, Operator-level user
• What success criteria will you use to evaluate a pilot (be specific: metrics, artifacts, stakeholder sign-offs)?
• When would you realistically be able to start a pilot? Options: Immediately (within 2 weeks), 2-4 weeks, 1-2 months, 3+ months
• What procurement, budget, or executive milestones must be cleared to proceed from pilot to contract?
• How would you prefer we follow up after this discovery session? Options: Executive summary + gap assessment, Technical deep-dive workshop, Pilot proposal with timeline and cost, Reference call with similar customer, All of the above